Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1989 Dec;42(12):1272–1275. doi: 10.1136/jcp.42.12.1272

Immunoreactive determinants of CA 125 in women with endometriosis.

O A Mojiminiyi 1, M E Bramwell 1, S H Kennedy 1, B J Shepstone 1, S M Humm 1, D H Barlow 1
PMCID: PMC502054  PMID: 2482302

Abstract

Among 10 patients with endometriosis CA 125 was increased (greater than 35 U/ml) in endometriotic cyst fluid in all the patients, but only two had increased serum concentrations. Gel electrophoresis of serum, endometriotic cyst fluid, and endometriotic tissue resolved the CA 125 immunoreactive fragments from the three sources into bands of similar electrophoretic mobilities. Electrophoresis under reducing and non-reducing conditions showed immunoreactive fragments of apparent masses of 55,000 and 140,000 daltons, respectively. Analysis under reducing conditions did not result in loss of activity. CA 125 antigen is thought to be a high molecular weight glycoprotein complex. As far as is known, this is the first report describing lower molecular weight immunoreactive determinants of CA 125.

Full text

PDF

Images in this article

1273Image
on p.1273
1273Image
on p.1273
1273Image
on p.1273

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bast R. C., Jr, Feeney M., Lazarus H., Nadler L. M., Colvin R. B., Knapp R. C. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest. 1981 Nov;68(5):1331–1337. doi: 10.1172/JCI110380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Davis H. M., Zurawski V. R., Jr, Bast R. C., Jr, Klug T. L. Characterization of the CA 125 antigen associated with human epithelial ovarian carcinomas. Cancer Res. 1986 Dec;46(12 Pt 1):6143–6148. [PubMed] [Google Scholar]
  3. Giudice L. C., Jacobs A., Pineda J., Bell C. E., Lippmann L. Serum levels of CA-125 in patients with endometriosis: a preliminary report. Fertil Steril. 1986 Jun;45(6):876–878. doi: 10.1016/s0015-0282(16)49409-4. [DOI] [PubMed] [Google Scholar]
  4. Halila H. Detection of ovarian cancer marker CA 125 in human seminal plasma. Tumour Biol. 1985;6(3):207–212. [PubMed] [Google Scholar]
  5. Hanisch F. G., Uhlenbruck G., Dienst C., Stottrop M., Hippauf E. Ca 125 and Ca 19-9: two cancer-associated sialylsaccharide antigens on a mucus glycoprotein from human milk. Eur J Biochem. 1985 Jun 3;149(2):323–330. doi: 10.1111/j.1432-1033.1985.tb08929.x. [DOI] [PubMed] [Google Scholar]
  6. Kennedy S. H., Soper N. D., Mojiminiyi O. A., Shepstone B. J., Barlow D. H. Immunoscintigraphy of ovarian endometriosis. A preliminary study. Br J Obstet Gynaecol. 1988 Jul;95(7):693–697. doi: 10.1111/j.1471-0528.1988.tb06532.x. [DOI] [PubMed] [Google Scholar]
  7. Koelma I. A., Nap M., Rodenburg C. J., Fleuren G. J. The value of tumour marker CA 125 in surgical pathology. Histopathology. 1987 Mar;11(3):287–294. doi: 10.1111/j.1365-2559.1987.tb02633.x. [DOI] [PubMed] [Google Scholar]
  8. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  9. Leoni F., Bast R. C., Jr, Canevari S., Menard S., Soper J. T., Colnaghi M. I. Immunochemical characterization and radioimmunometric detection of molecules shed by human ovarian cancer. Int J Cancer. 1987 Nov 15;40(5):592–597. doi: 10.1002/ijc.2910400503. [DOI] [PubMed] [Google Scholar]
  10. Mainguené C., Aillet G., Kremer M., Chatal J. F. Immunohistochemical study of ovarian tumors using the OC 125 monoclonal antibody as a basis for potential in vivo and in vitro applications. J Nucl Med Allied Sci. 1986 Jan-Mar;30(1):19–22. [PubMed] [Google Scholar]
  11. Masuho Y., Zalutsky M., Knapp R. C., Bast R. C., Jr Interaction of monoclonal antibodies with cell surface antigens of human ovarian carcinomas. Cancer Res. 1984 Jul;44(7):2813–2819. [PubMed] [Google Scholar]
  12. Matsuoka Y., Nakashima T., Endo K., Yoshida T., Kunimatsu M., Sakahara H., Koizumi M., Nakagawa T., Yamaguchi N., Torizuka K. Recognition of ovarian cancer antigen CA125 by murine monoclonal antibody produced by immunization of lung cancer cells. Cancer Res. 1987 Dec 1;47(23):6335–6340. [PubMed] [Google Scholar]
  13. Nouwen E. J., Hendrix P. G., Dauwe S., Eerdekens M. W., De Broe M. E. Tumor markers in the human ovary and its neoplasms. A comparative immunohistochemical study. Am J Pathol. 1987 Feb;126(2):230–242. [PMC free article] [PubMed] [Google Scholar]
  14. Nouwen E. J., Pollet D. E., Eerdekens M. W., Hendrix P. G., Briers T. W., De Broe M. E. Immunohistochemical localization of placental alkaline phosphatase, carcinoembryonic antigen, and cancer antigen 125 in normal and neoplastic human lung. Cancer Res. 1986 Feb;46(2):866–876. [PubMed] [Google Scholar]
  15. O'Brien T. J., Hardin J. W., Bannon G. A., Norris J. S., Quirk J. G., Jr CA 125 antigen in human amniotic fluid and fetal membranes. Am J Obstet Gynecol. 1986 Jul;155(1):50–55. doi: 10.1016/0002-9378(86)90076-1. [DOI] [PubMed] [Google Scholar]
  16. Patton P. E., Field C. S., Harms R. W., Coulam C. B. CA-125 levels in endometriosis. Fertil Steril. 1986 Jun;45(6):770–773. doi: 10.1016/s0015-0282(16)49390-8. [DOI] [PubMed] [Google Scholar]
  17. Shishi J., Ghazizadeh M., Oguro T., Aihara K., Araki T. Immunohistochemical localization of CA 125 antigen in formalin-fixed paraffin sections of ovarian tumors with the use of Pronase. Am J Clin Pathol. 1986 May;85(5):595–598. doi: 10.1093/ajcp/85.5.595. [DOI] [PubMed] [Google Scholar]
  18. Studier F. W. Analysis of bacteriophage T7 early RNAs and proteins on slab gels. J Mol Biol. 1973 Sep 15;79(2):237–248. doi: 10.1016/0022-2836(73)90003-x. [DOI] [PubMed] [Google Scholar]
  19. Ward B. G., Cruickshank D. J., Tucker D. F., Love S. Independent expression in serum of three tumour-associated antigens: CA 125, placental alkaline phosphatase and HMFG2 in ovarian carcinoma. Br J Obstet Gynaecol. 1987 Jul;94(7):696–698. doi: 10.1111/j.1471-0528.1987.tb03178.x. [DOI] [PubMed] [Google Scholar]
  20. de Bruijn H. W., van Beeck Calkoen-Carpay T., Jager S., Duk J. M., Aalders J. G., Fleuren G. J. The tumor marker CA 125 is a common constituent of normal cervical mucus. Am J Obstet Gynecol. 1986 May;154(5):1088–1091. doi: 10.1016/0002-9378(86)90757-x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES